SpyGlass Pharma, Inc. (SGP)
24.00
-0.72
(-2.91%)
USD |
NASDAQ |
Oct 16, 16:00
24.16
+0.16
(+0.67%)
After-Hours: 20:00
SpyGlass Pharma Market Cap : 802.71M for Oct. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 16, 2026 | 802.71M |
| October 15, 2026 | 826.79M |
| October 14, 2026 | 792.34M |
| October 13, 2026 | 800.04M |
| October 12, 2026 | 831.48M |
| October 09, 2026 | 833.48M |
| October 08, 2026 | 823.45M |
| October 07, 2026 | 799.37M |
| October 06, 2026 | 828.80M |
| October 05, 2026 | 855.89M |
| October 02, 2026 | 833.48M |
| October 01, 2026 | 886.33M |
| September 30, 2026 | 869.60M |
| September 29, 2026 | 850.87M |
| September 28, 2026 | 868.93M |
| September 25, 2026 | 905.39M |
| September 24, 2026 | 924.79M |
| September 23, 2026 | 941.85M |
| September 22, 2026 | 959.57M |
| September 21, 2026 | 935.16M |
| September 18, 2026 | 972.62M |
| September 17, 2026 | 980.98M |
| September 16, 2026 | 956.56M |
| September 15, 2026 | 968.60M |
| September 14, 2026 | 958.57M |
| Date | Value |
|---|---|
| September 11, 2026 | 920.44M |
| September 10, 2026 | 913.42M |
| September 09, 2026 | 919.77M |
| September 08, 2026 | 967.27M |
| September 04, 2026 | 967.94M |
| September 03, 2026 | 969.61M |
| September 02, 2026 | 945.86M |
| September 01, 2026 | 898.37M |
| August 31, 2026 | 872.95M |
| August 28, 2026 | 883.65M |
| August 27, 2026 | 900.71M |
| August 26, 2026 | 891.01M |
| August 25, 2026 | 889.67M |
| August 24, 2026 | 878.30M |
| August 21, 2026 | 886.66M |
| August 20, 2026 | 877.30M |
| August 19, 2026 | 910.74M |
| August 18, 2026 | 864.25M |
| August 17, 2026 | 862.25M |
| August 14, 2026 | 876.29M |
| August 13, 2026 | 841.84M |
| August 12, 2026 | 845.19M |
| August 11, 2026 | 831.14M |
| August 10, 2026 | 841.51M |
| August 07, 2026 | 846.53M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.661B |
| Corcept Therapeutics, Inc. | 11.89B |
| Veru, Inc. | 39.22M |
| Johnson & Johnson | 615.45B |
| Eli Lilly & Co. | 1.183T |
Market Cap Related Metrics
| Price to Book Value | 3.454 |
| Price | 24.00 |
| Earnings Yield | -8.01% |